Teacher Retirement System of Texas lifted its stake in Catalent Inc (NYSE:CTLT) by 340.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 45,341 shares of the company’s stock after purchasing an additional 35,041 shares during the period. Teacher Retirement System of Texas’ holdings in Catalent were worth $1,863,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. American Century Companies Inc. boosted its stake in Catalent by 755.3% in the fourth quarter. American Century Companies Inc. now owns 2,631,643 shares of the company’s stock valued at $108,108,000 after acquiring an additional 2,323,971 shares during the last quarter. Eagle Asset Management Inc. boosted its stake in Catalent by 290.9% in the third quarter. Eagle Asset Management Inc. now owns 1,153,710 shares of the company’s stock valued at $47,636,000 after acquiring an additional 858,600 shares during the last quarter. Emerald Advisers Inc. PA boosted its stake in Catalent by 1,072.2% in the third quarter. Emerald Advisers Inc. PA now owns 604,207 shares of the company’s stock valued at $24,120,000 after acquiring an additional 552,663 shares during the last quarter. Emerald Mutual Fund Advisers Trust bought a new position in Catalent in the third quarter valued at approximately $18,420,000. Finally, Macquarie Group Ltd. boosted its stake in Catalent by 15.8% in the third quarter. Macquarie Group Ltd. now owns 2,069,323 shares of the company’s stock valued at $82,607,000 after acquiring an additional 282,559 shares during the last quarter. 99.82% of the stock is owned by institutional investors and hedge funds.
A number of brokerages have issued reports on CTLT. Goldman Sachs Group began coverage on shares of Catalent in a research note on Wednesday, January 24th. They issued a “buy” rating and a $50.00 price objective on the stock. Royal Bank of Canada set a $48.00 price objective on shares of Catalent and gave the company a “buy” rating in a research note on Monday, February 5th. Stephens cut shares of Catalent from an “overweight” rating to an “equal weight” rating in a research note on Tuesday, February 6th. Zacks Investment Research raised shares of Catalent from a “hold” rating to a “buy” rating and set a $48.00 price objective on the stock in a research note on Wednesday, January 17th. Finally, Bank of America raised their price objective on shares of Catalent from $47.00 to $49.00 and gave the company a “buy” rating in a research note on Tuesday, February 6th. Six equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $45.70.
In other news, insider John R. Chiminski sold 181,458 shares of Catalent stock in a transaction on Tuesday, December 12th. The shares were sold at an average price of $39.62, for a total transaction of $7,189,365.96. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.70% of the company’s stock.
Catalent Inc (CTLT) opened at $42.84 on Friday. The firm has a market cap of $5,655.38, a price-to-earnings ratio of 26.51, a PEG ratio of 2.43 and a beta of 1.47. Catalent Inc has a 52-week low of $27.48 and a 52-week high of $47.87. The company has a current ratio of 2.22, a quick ratio of 1.78 and a debt-to-equity ratio of 2.66.
Catalent (NYSE:CTLT) last announced its quarterly earnings results on Monday, February 5th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.31 by $0.10. The company had revenue of $606.30 million for the quarter, compared to analysts’ expectations of $565.05 million. Catalent had a net margin of 3.03% and a return on equity of 23.85%. The business’s quarterly revenue was up 25.3% compared to the same quarter last year. During the same period last year, the firm posted $0.27 earnings per share. research analysts anticipate that Catalent Inc will post 1.53 EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Teacher Retirement System of Texas Raises Position in Catalent Inc (CTLT)” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/24/teacher-retirement-system-of-texas-raises-position-in-catalent-inc-ctlt.html.
Catalent Company Profile
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Receive News & Ratings for Catalent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent and related companies with MarketBeat.com's FREE daily email newsletter.